| http://www.w3.org/ns/prov#value | - Amylin Pharmaceuticals is a ... submitted and/or accepted in a timely manner; regulatory approval being delayed or not received; or ... the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the ...Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine... and the development of our produ
|
